METHOD FOR PREDICTION OF OVERALL SURVIVAL OF MALE PATIENTS WITH CHRONIC LYMPHATIC LEUKEMIA IN STAGE A-C

• 1. 一种慢性淋巴细胞白血病SSCR风险模型及其建立方法和应用 [P] . 中国专利： CN113782087B . 2022.01.18
• 2. 基于机器学习的慢性淋巴细胞白血病肿瘤细胞识别方法 [P] . 中国专利： CN111257558B . 2021.08.24
• 3. METHOD FOR PREDICTION OF OVERALL SURVIVAL OF MALE PATIENTS WITH CHRONIC LYMPHATIC LEUKEMIA IN STAGE A-C [P] . 俄罗斯专利： RU0002725877C1 . 2020.07.07
• 4. METHOD FOR PREDICTION OF OVERALL SURVIVAL IN PATIENTS WITH CHRONIC LYMPHATIC LEUKAEMIA [P] . 俄罗斯专利： RU2498313C1 . 2013-11-10

  机译： 预测慢性淋巴白血病患者总生存率的方法

• 5. METHOD FOR PREDICTING THE RISK OF DEVELOPING SUBCLINICAL LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN THE PATIENTS WITH CHRONIC LYMPHATIC LEUKEMIA IN THE CHEMOTHERAPY IN THE FCR MODE [P] . 俄罗斯专利： RU2727003C1 . 2020-07-17

  机译： 在FCR模式下预测慢性淋巴白血病患者化疗后亚临床左室收缩功能异常发展风险的方法

• 1. Gene mutations in a patient with chronic myelomonocytic leukemia and changes upon progression to acute myeloid leukemia and during treatment [J] . Jiaming Li, Sujiang Zhang 肿瘤学与转化医学（英文） . 2019,第001期
• 2. Prediction of response and survival in patients with chronic-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate: logistic regression and landmark analyses [J] . M Wetzler, H M Kantarjian, F E Nicolini, Blood cancer journal. . 2015,第12期
• 3. Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: Results of the multicenter O-CLL1-GISL study [J] . GentileM., CutronaG., MoscaL., American Journal of Hematology . 2014,第7期
• 4. Proteomics Analysis Reveals Protein Panels That Are Associated with Prediction to Tyrosine Kinase Inhibitors Response, Bone Marrow Transplant, Survival and Disease Outcome of Chronic Myeloid Leukemia Patients [J] . Alaiya Ayodele, Aljurf Mahmoud, Shinwari Zakia, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期
• 5. Predicting Time to First Treatment in Chronic Lymphocytic Leukemia Using Machine Learning Survival and Classification Methods [C] . David Chen, Gaurav Goyal, Ronald Go, IEEE International Conference on Healthcare Informatics . 2018
• 6. Influences on physician recommendation for imatinib mesylate in chronic phase chronic myeloid leukemia patients. [D] . Iyer, Shrividya Sethuraman. 2003
• 7. Prediction of response and survival in patients with chronic-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate: logistic regression and landmark analyses [O] . M Wetzler, H M Kantarjian, F E Nicolini, 2015
• 8. Prediction of response and survival in patients with chronic-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate: logistic regression and landmark analyses [O] . M Wetzler, H M Kantarjian, F E Nicolini, 2015

• 1. Overall Survival and Health Care Costs of Medicare Patients with Previously Treated Chronic Lymphocytic Leukemia [J] . Carolina Reyes ,Genevieve Gauthier ,Sherry Shi . 癌症治疗（英文） . 2018,第7期
• 2. The Effect of Curcumin (as Meriva) on Absolute Lymphocyte Count (ALC), NK Cells and T Cell Populations in Patients with Stage 0/1 Chronic Lymphocytic Leukemia [J] . Terry Golombick ,Terrence H. Diamond ,Arumugam Manoharan . 癌症治疗（英文） . 2015,第7期
• 3. Construction of Parsimonious Event Risk Scores by an Ensemble Method. An Illustration for Short-Term Predictions in Chronic Heart Failure Patients from the GISSI-HF Trial [J] . Beno#238 ,t Lalloué ,Jean-Marie Monnez . 应用数学（英文） . 2021,第7期
• 4. Probability Prediction in Multistate Survival Models for Patients with Chronic Myeloid Leukaemia [J] . FANG Ya ,Hein Putter . 华中科技大学学报（医学）（英德文版） . 2005,第001期
• 5. 慢性粒细胞白血病髓外淋巴结急变期一例并文献复习 [C] . 白聪 ,高子芬 . 中国老年学学会老年肿瘤专业委员会2015年淋巴血液肿瘤分会年会 . 2015
• 6. 术前中性粒细胞与淋巴细胞比值预测BCLC A-C期肝癌切除术后预后的效果 [A] . 左宏平 . 2018